Gary J. Noel - Concepedia

Author

Gary J. Noel

Cornell University ORCID

Also Known As

&NA;, G J Noel, G Noel, G. J. Noel, G. Noel, G. Noël, G. Noël, G.J. Noel, GARY J. NOEL, Gary J Noel

119

Publications

4.2K

Citations

H-Index

114

Concepts

All Affiliations

Cornell University Johnson & Johnson (United States)NewYork–Presbyterian Hospital United States Food and Drug Administration Rainbow Babies & Children's Hospital

About

Gary J. Noel is an author at Cornell University specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	29	1.7K
2	Health Sciences	11	11	541
3	Education	2	2	47
4	Arts	1	1	19
5	Public Health	1	1	13

Gary J. Noel

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Selective Suppression of Interleukin-12 Induction after Macrophage Receptor Ligation Fayyaz S. Sutterwala, Gary J. Noel, Raphael Clynes, The Journal of Experimental Medicine Il-12 InductionImmunologyImmune RegulationSelective SuppressionImmunologic Mechanism	1997	355
Reversal of Proinflammatory Responses by Ligating the Macrophage Fcγ Receptor Type I Fayyaz S. Sutterwala, Gary J. Noel, Padmini Salgame, The Journal of Experimental Medicine	1998	324
A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections Gary J. Noel, Karen Bush, Partha Bagchi, Clinical Infectious Diseases	2008	267
Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria Gary J. Noel, Karen Amsler, M. Heep, Antimicrobial Agents and Chemotherapy Antimicrobial SusceptibilityHealth SciencesAntibioticsVancomycin 1Complicated Skin	2007	188
Abnormal Regulation of Interferon‐γ, Interleukin‐12, and Tumor Necrosis Factor‐α in Human Interferon‐g Receptor 1 Deficiency Steven M. Holland, Susan E. Dorman, Annette Kwon, The Journal of Infectious Diseases ImmunodeficienciesImmunologyImmune RegulationPathologyNormal Ifn-gamma	1998	152
A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation Susan Nicholson, Tobias Welte, Thomas M. File, International Journal of Antimicrobial Agents Community-acquired PneumoniaCeftobiprole MedocarilAntimicrobial StewardshipKlebsiella PneumoniaeDouble-blind Trial	2012	150
Effects of three fluoroquinolones on QT interval in healthy adults after single doses Gary J. Noel Clinical Pharmacology & Therapeutics	2003	150
Prevalence and Antifungal Susceptibility of 442 <i>Candida</i> Isolates from Blood and Other Normally Sterile Sites: Results of a 2-Year (1996 to 1998) Multicenter Surveillance Study in Quebec, Canada G. St‐Germain, Michél Laverdière, René Pelletier, Journal of Clinical Microbiology	2001	132
Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population John D. Seeger, William A. West, Daniel Fife, Pharmacoepidemiology and Drug Safety	2006	104
Comparative Safety Profile of Levofloxacin in 2523 Children With a Focus on Four Specific Musculoskeletal Disorders Gary J. Noel, John S. Bradley, Ralph E. Kauffman, The Pediatric Infectious Disease Journal	2007	100

Page 1